VITR.ST
Price:
$239
Market Cap:
$32.36B
Vitrolife AB (publ), a medical device company, develops, produces, and markets products for assisted reproduction. It provides oocyte retrieval needles; sperm processing; in vitro fertilization media and oil; micromanipulation pipettes; labware; incubators; cryopreservation; and preimplantation genetic testing products. The company also offers EmbryoScope and Primo Vision time-lapse systems; time-lapse dishes; evaluation tools for time-lapse systems; and Octax laser and imaging systems, as well as log and guard systems and wireless sensors. It operates in Europe, the Middle East, and Africa; Asia; Japan and Pacific; and North and South America. The company was formerly known as Scandinavian ...[Read more]
Industry
Medical - Devices
IPO Date
2001-06-28
Stock Exchange
STO
Ticker
VITR.ST
According to Vitrolife AB (publ)’s latest financial reports and current stock price. The company's current PE Ratio is -8.50. This represents a change of -119.95% compared to the average of 42.60 of the last 4 quarters.
The mean historical PE Ratio of Vitrolife AB (publ) over the last ten years is 59.61. The current -8.50 PE Ratio has changed -1525.95% with respect to the historical average. Over the past ten years (40 quarters), VITR.ST's PE Ratio was at its highest in in the June 2020 quarter at 486.49. The PE Ratio was at its lowest in in the December 2023 quarter at -1.58.
Average
59.61
Median
52.12
Minimum
-6.85
Maximum
188.24
Discovering the peaks and valleys of Vitrolife AB (publ) PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 130.50%
Maximum Annual PE Ratio = 188.24
Minimum Annual Increase = -110.70%
Minimum Annual PE Ratio = -6.85
Year | PE Ratio | Change |
---|---|---|
2023 | -6.85 | -110.70% |
2022 | 63.99 | -66.01% |
2021 | 188.24 | 130.50% |
2020 | 81.67 | 45.81% |
2019 | 56.01 | 6.46% |
2018 | 52.61 | 1.90% |
2017 | 51.63 | 16.99% |
2016 | 44.13 | 28.84% |
2015 | 34.26 | 12.65% |
2014 | 30.41 | -8.44% |
The current PE Ratio of Vitrolife AB (publ) (VITR.ST) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
81.79
5-year avg
76.61
10-year avg
59.61
Vitrolife AB (publ)’s PE Ratio is
Company | PE Ratio | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vitrolife AB (publ) using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Vitrolife AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Vitrolife AB (publ)'s PE Ratio?
How is the PE Ratio calculated for Vitrolife AB (publ) (VITR.ST)?
What is the highest PE Ratio for Vitrolife AB (publ) (VITR.ST)?
What is the 3-year average PE Ratio for Vitrolife AB (publ) (VITR.ST)?
What is the 5-year average PE Ratio for Vitrolife AB (publ) (VITR.ST)?
How does the current PE Ratio for Vitrolife AB (publ) (VITR.ST) compare to its historical average?